Accuray Incorporated (ARAY) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.228x

Based on the latest financial reports, Accuray Incorporated (ARAY) has a cash flow conversion efficiency ratio of -0.228x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-12.18 Million) by net assets ($53.42 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Accuray Incorporated - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Accuray Incorporated's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Accuray Incorporated for a breakdown of total debt and financial obligations.

Accuray Incorporated Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Accuray Incorporated ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Malaysia Steel Works KL Bhd
KLSE:5098
0.065x
Po Valley Energy Ltd
AU:PVE
0.106x
Kalray SA
PA:ALKAL
-0.167x
Ithaca Energy PLC
LSE:ITH
0.093x
Ocumetics Technology Corp
V:OTC
0.214x
Reliance Securities Tbk
JK:RELI
-0.069x
Unlu Yatirim Holding AS
IS:UNLU
-0.041x
Enwell Energy plc
F:RHN
-0.003x

Annual Cash Flow Conversion Efficiency for Accuray Incorporated (2005–2025)

The table below shows the annual cash flow conversion efficiency of Accuray Incorporated from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Accuray Incorporated worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 $81.17 Million $2.86 Million 0.035x +113.34%
2024-06-30 $45.08 Million $-11.90 Million -0.264x -191.18%
2023-06-30 $53.66 Million $15.54 Million 0.290x +741.79%
2022-06-30 $53.19 Million $-2.40 Million -0.045x -108.07%
2021-06-30 $68.84 Million $38.51 Million 0.559x +2523.42%
2020-06-30 $63.63 Million $-1.47 Million -0.023x +96.12%
2019-06-30 $49.87 Million $-29.64 Million -0.594x -257.68%
2018-06-30 $48.63 Million $18.33 Million 0.377x +4715.74%
2017-06-30 $46.53 Million $-380.00K -0.008x -101.45%
2016-06-30 $59.66 Million $33.54 Million 0.562x +354.59%
2015-06-30 $75.78 Million $-16.73 Million -0.221x -6389.14%
2014-06-30 $98.55 Million $346.00K 0.004x +100.57%
2013-06-30 $106.83 Million $-66.18 Million -0.619x -229.90%
2012-06-30 $203.87 Million $-38.28 Million -0.188x -463.82%
2011-06-30 $240.33 Million $12.40 Million 0.052x +273.02%
2010-06-30 $170.08 Million $-5.07 Million -0.030x +42.95%
2009-06-30 $153.90 Million $-8.05 Million -0.052x +62.00%
2008-06-30 $130.76 Million $-17.99 Million -0.138x -248.81%
2007-06-30 $125.44 Million $11.60 Million 0.092x +129.31%
2006-06-30 $-80.86 Million $25.50 Million -0.315x +1.64%
2005-06-30 $-56.17 Million $18.02 Million -0.321x --

About Accuray Incorporated

NASDAQ:ARAY USA Medical Devices
Market Cap
$53.27 Million
Market Cap Rank
#21663 Global
#4603 in USA
Share Price
$0.47
Change (1 day)
+0.66%
52-Week Range
$0.34 - $1.85
All Time High
$7.46
About

Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation t… Read more